Rashi Fein, Harvard Professor Known as A ‘Father of Medicare,’ Dies
Rashi Fein, left, and his brother Leonard Fein. Image by Courtesy of Mazon
Rashi Fein, a Harvard professor known for his contributions to medicine and social policy, has died.
Fein, a professor emeritus of economics of medicine at Harvard Medical School, was the brother of Jewish activist and writer Leonard Fein, who died nearly a month ago. He was instrumental in the development of U.S. health policy, beginning with the Truman administration. Fein served as a senior staff member of President Kennedy’s Council of Economic Advisors and is considered by many as one of the “fathers of Medicare,” according to the Jewish Alliance for Law and Social Action. Fein served on the Advisory Committee of the alliance.
“A love of his Yiddish heritage, a passion for social justice, and a strong Zionist, he was always available to consider, discuss, and critique policies undertaken both by the U.S. and Israeli governments,” the alliance said in a statement.
Fein also served as a senior fellow in the Brookings Institution’s economics program and as chair of the National Advisory Committee for the Robert Wood Johnson Foundation Scholars in Health Policy Research Program from 1994 to 2002.
He was honored by national and local organizations for his contributions to medicine and social policy.
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.
If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.
Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism.
— Rachel Fishman Feddersen, Publisher and CEO
